Averica Discovery Services, an analytical development contract research organization (CRO), has acquired new equipment that it says significantly expands the its capacity and capability. Averica offers analytical development services to pharmaceutical companies, supporting new drug profiling, early to mid-stage clinical development, and CMC.

The new instrument systems include a new preparative supercritical fluid chromatography (SFC) system, mass-directed preparative HPLC systems, and a charged aerosol detector (CAD). The additions enhance the company’s ability to supply early drug development programs while shortening project timelines.

Averica has also filled three new laboratory positions.

“Averica is growing dramatically,” said Jeffery Kiplinger, president, Averica. “Our analytical technologies and scientists are critical to the high quality services we provide. The added preparative chromatography capabilities will offer more capacity for our core services. The new detectors will enable support for new types of client projects, continuing Averica’s growth trajectory.”